Researchers have identified ARMC5 as a key regulator of fatty acid balance in adipose tissue. ARMC5 degrades non-SCAP-bound SREBP1, activating it to regulate stearoyl-CoA desaturase (SCD), an enzyme essential for fatty acid desaturation. This discovery opens avenues for developing drugs targeting ARMC5 to manage fatty acid levels and improve health outcomes.
